• Explore /
  • Poster
  • / A phase II trial of cemiplimab alone or in combination with standard of care chemotherapy in locally advanced or metastatic penile carcinoma (EPIC trial).

A phase II trial of cemiplimab alone or in combination with standard of care chemotherapy in locally advanced or metastatic penile carcinoma (EPIC trial).

Abstract Poster

Authors

null

Amit Bahl

Bristol Haematology and Oncology Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom

Amit Bahl , Emily Foulstone , Lauren Ashurst , Emily Renninson , Paul White , Alicia Bravo , Mehran Afshar , Constantine Alifrangis , Balaji Venugopal , Alastair Thomson , Anna Tran , Jim Barber , Helen Clare Dearden , Christopher Kent , Vivekanandan Kumar , Mark Callaway , Amarnath Challapalli

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

95561634

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr TPS14)

DOI

10.1200/JCO.2024.42.4_suppl.TPS14

Abstract #

TPS14

Poster Bd #

M5

Abstract Disclosures

Similar Posters

First Author: Emily Renninson

First Author: Antoine Thiery-Vuillemin

First Author: Robert A. Ramirez

First Author: Matt D. Galsky